Comparing IV methadone versus IV remifentanil for pain and recovery after craniotomy
Official title: Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
Run by University of Virginia · NCT06810336 · Data updated 2026-11-12
This trial will test whether a single dose of IV methadone given during surgery provides better pain control and recovery than IV remifentanil for adults having supratentorial craniotomy.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Virginia Academic / other |
| Locations | 1 site (Charlottesville, Virginia) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | September 10, 2027 |
| Study ends | September 10, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06810336 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 undergoing elective supratentorial intracranial surgery with ASA I–III, BMI 18.5–45, able to read English, and not using chronic daily opioids or medications for opioid use disorder are ideal candidates.
✕Probably not a fit
Patients on chronic high-dose opioids, active treatment for opioid use disorder, emergent surgical cases, those with methadone use or allergy, or significant renal failure are excluded and unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, early phase 1 interventional trial randomly compares intraoperative IV methadone to IV remifentanil in adult patients undergoing elective supratentorial craniotomy. Participants receive one of the two opioid strategies during surgery and are followed for postoperative pain scores, opioid consumption (MME), nausea/vomiting, and recovery parameters for the early postoperative period. The trial excludes patients on chronic high-dose opioids, those with active substance use disorder, methadone exposure or allergy, emergent surgeries, or significant renal impairment. Safety monitoring emphasizes neurologic exam reliability and respiratory depression given the different opioid profiles.
Why it matters
Potential benefit: If successful, the approach could give longer-lasting pain relief after craniotomy, reduce postoperative opioid needs, and lower pain-related complications.
How similar studies have gone: Previous randomized and observational work in orthopedic, abdominal, spine, cardiac, obstetric, and gynecologic surgeries has shown IV methadone can lower postoperative pain and opioid use, and retrospective data suggest benefit after intracranial surgery, but randomized head-to-head comparisons in craniotomy patients are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult Patients between ages 18 and 65 years old. 2. Undergoing supratentorial intracranial surgery 3. American Society of Anesthesiologists (ASA) physiological status I-III 4. Body Mass Index (BMI) between 18.5 and 45 5. Ability to understand and read English Exclusion Criteria: 1. Being unable or unwilling to sign a consent 2. Anticipated discharge within 24 hours after surgery 3. Patients requiring Emergent Surgery 4. Preoperative usage of Methadone, or allergy to it. 5. Patients with chronic pain, requiring daily opioid use at the time of surgery, MME \>60 as FDA defines opioid tolerant as 60 MME, long-acting forms of opioids such as fentanyl patch, oxycontin 6. Active or Prior Substance Use Disorder, undergoing active treatment with Medication of Opioid Use Disorder including methadone (once daily dosing), Buprenorphine (any formulation) and Naltrexone 7. Preoperative chronic renal insufficiency or failure (defined as a serum creatinine more than 2 mg/dl), 8. Pregnancy 9. Significant liver disease (cirrhosis or hepatic failure) 10. QTc \>450 on preoperative electrocardiogram 11. Pulmonary disease necessitating home oxygen therapy 12. Inability to speak or read the English language
Where it's running
-
University of Virginia
Charlottesville, Virginia, United States Recruiting
Study contacts
- Study coordinator: Jennifer Phillips, RN
- Email: JVP8A@virginia.edu
- Phone: 434-297-8136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploration of whole-brain radiotherapy with PD-1 inhibitors for brain injury in SCLC
This study tests whether adding PD-1 inhibitors to chemotherapy and prophylactic brain irradiation helps some small cell lung cancer patients protect the brain.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Timing of Postoperative ICU Complications in the First 24 Hours
This study tests how often and when serious problems occur in adults during the first 24 hours after ICU admission for postoperative monitoring.
-
Postoperative Atrial Pacing in Children After Heart Surgery
This study tests whether briefly raising a child’s heart rate after heart surgery improves blood flow and oxygen delivery by using temporary atrial pacing at 10 or 20 beats per minute above the child’s natural rate.
-
Smart Holistic Health Care Platform for families of children with cancer
Aims to see if two smart platforms for parents and children with leukemia or brain tumors in Taiwan can improve quality of life and overall well-being during treatment.
-
Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS
This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.